198 related articles for article (PubMed ID: 35502827)
1. N
Zhang Z; Xing Y; Gao W; Yang L; Shi J; Song W; Li T
Bioengineered; 2022 May; 13(5):11541-11550. PubMed ID: 35502827
[TBL] [Abstract][Full Text] [Related]
2. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m
Shi Y; Xiong X; Sun Y; Geng Z; Chen X; Cui X; Lv J; Ge L; Jia X; Xu J
FASEB J; 2023 Oct; 37(10):e23183. PubMed ID: 37665628
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA HOXC-AS1 exerts its oncogenic effects in esophageal squamous cell carcinoma by interaction with IGF2BP2 to stabilize SIRT1 expression.
Yang Z; Wan J; Ma L; Li Z; Yang R; Yang H; Li J; Zhou F; Ming L
J Clin Lab Anal; 2023 Jan; 37(1):e24801. PubMed ID: 36510377
[TBL] [Abstract][Full Text] [Related]
5. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
6. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract][Full Text] [Related]
7. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway.
Liu D; Xia AD; Wu LP; Li S; Zhang K; Chen D
Cell Signal; 2022 Jun; 94():110313. PubMed ID: 35306138
[TBL] [Abstract][Full Text] [Related]
9. IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader.
Hu X; Peng WX; Zhou H; Jiang J; Zhou X; Huang D; Mo YY; Yang L
Cell Death Differ; 2020 Jun; 27(6):1782-1794. PubMed ID: 31804607
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.
Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F
Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831
[TBL] [Abstract][Full Text] [Related]
11. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
12. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer.
Wu H; Ding X; Hu X; Zhao Q; Chen Q; Sun T; Li Y; Guo H; Li M; Gao Z; Yao W; Zhao L; Li K; Wei M
Oncogene; 2022 Mar; 41(13):1959-1973. PubMed ID: 35173309
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP2 Promotes Epithelial to Mesenchymal Transition and Metastasis through Stabilizing HMGA1 mRNA in Gastric Cancer.
Ouyang J; Li J; Li D; Jiang J; Hao T; Xia Y; Lu X; Zhang C; He Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358799
[TBL] [Abstract][Full Text] [Related]
14. N
Luo F; Lin K
Exp Cell Res; 2022 Aug; 417(1):113176. PubMed ID: 35489385
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.
Wang Y; Lu JH; Wu QN; Jin Y; Wang DS; Chen YX; Liu J; Luo XJ; Meng Q; Pu HY; Wang YN; Hu PS; Liu ZX; Zeng ZL; Zhao Q; Deng R; Zhu XF; Ju HQ; Xu RH
Mol Cancer; 2019 Dec; 18(1):174. PubMed ID: 31791342
[TBL] [Abstract][Full Text] [Related]
16. IGF2BP2-meidated m
Ji R; Wu C; Yao J; Xu J; Lin J; Gu H; Fu M; Zhang X; Li Y; Zhang X
Cell Death Dis; 2023 Oct; 14(10):693. PubMed ID: 37865637
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine reader YTH N6-methyladenosine RNA binding protein 3 or insulin like growth factor 2 mRNA binding protein 2 knockdown protects human bronchial epithelial cells from hypoxia/reoxygenation injury by inactivating p38 MAPK, AKT, ERK1/2, and NF-κB pathways.
Xiao K; Liu P; Yan P; Liu Y; Song L; Liu Y; Xie L
Bioengineered; 2022 May; 13(5):11973-11986. PubMed ID: 34709120
[TBL] [Abstract][Full Text] [Related]
18. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
Yang J; Xu P; Chen Z; Zhang X; Xia Y; Fang L; Xie L; Li B; Xu Z
Cancer Lett; 2023 Apr; 558():216092. PubMed ID: 36806557
[TBL] [Abstract][Full Text] [Related]
19. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
20. IGF2BP2 promotes cancer progression by degrading the RNA transcript encoding a v-ATPase subunit.
Latifkar A; Wang F; Mullmann JJ; Panizza E; Fernandez IR; Ling L; Miller AD; Fischbach C; Weiss RS; Lin H; Cerione RA; Antonyak MA
Proc Natl Acad Sci U S A; 2022 Nov; 119(45):e2200477119. PubMed ID: 36322753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
